Brief: Reneo Pharmaceuticals Reports Q1 2023 Financial Results
May 11 (Reuters) - Reneo Pharmaceuticals Inc RPHM.O :
* RENEO PHARMACEUTICALS REPORTS FIRST QUARTER 2023 FINANCIAL
RESULTS
* RENEO PHARMACEUTICALS INC Q1 LOSS PER SHARE $0.60
* RENEO PHARMACEUTICALS INC Q1 EARNINGS PER SHARE VIEW
$-0.60 --
REFINITIV IBES DATA
Source text for Eikon: ID:nGNXb2cFG1
Further company coverage: RPHM.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Onkure Therapeutics
See all newsBrief: Onkure Therapeutics Inc Files For Mixed Shelf Of Up To $200 Million - SEC Filing
Onkure Therapeutics Inc reports results for the quarter ended June 30 - Earnings Summary
Onkure Therapeutics Inc reports results for the quarter ended March 31 - Earnings Summary
Onkure Therapeutics Inc expected to post a loss of $1.46 a share - Earnings Preview
U.S. RESEARCH ROUNDUP-F5, Nextracker, Stryker